BrainsWay Welcomes New Chief Medical Officer
Company Announcements

BrainsWay Welcomes New Chief Medical Officer

Brainsway (BWAY) has released an update.

BrainsWay Ltd., a leader in noninvasive neurostimulation treatments for mental health, has appointed Dr. Richard A. Bermudes as its new Chief Medical Officer. Dr. Bermudes brings over 20 years of experience in TMS and brain stimulation therapies to the company. This strategic hire is aimed at advancing BrainsWay’s clinical strategy and product development in the mental health sector.

For further insights into BWAY stock, check out TipRanks’ Stock Analysis page.

Related Articles
Brian AndersonIs BWAY a Buy, Before Earnings?
TipRanks Auto-Generated NewsdeskBrainsWay Secures $20 Million in Strategic Investment
TheFlySmall early trial shows brain stimulation may slow Alzheimer symptoms, NBC says
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App